Analyst Price Target is $5.10
▲ +56.20% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for Definitive Healthcare in the last 3 months. The average price target is $5.10, with a high forecast of $7.50 and a low forecast of $3.00. The average price target represents a 56.20% upside from the last price of $3.27.
Current Consensus is
Reduce
The current consensus among 10 contributing investment analysts is to reduce stock in Definitive Healthcare. This rating changed within the last month from a Hold consensus rating.
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Read More
